PTC Therapeutics, Inc. (PTCT) stock
PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3028% above fair value
$60.36−0.61 (-1.00%)
Close on Nov 17, 2026Market cap $5.04BP/E –Yield –
PTC Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
PTC Therapeutics's operating cash flow for the twelve months ending Sep 30, 2026 was $10.49M, down 98.5% year over year. For fiscal 2025 it was $711.20M. The highest annual figure on record is $711.20M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $711.20M | – |
| FY2024 | Dec 31, 2024 | -$107.69M | – |
| FY2023 | Dec 31, 2023 | -$158.42M | – |
| FY2022 | Dec 31, 2022 | -$356.65M | – |
| FY2021 | Dec 31, 2021 | -$251.33M | – |
| FY2020 | Dec 31, 2020 | -$194.07M | – |
| FY2019 | Dec 31, 2019 | -$98.64M | – |
| FY2018 | Dec 31, 2018 | -$27.64M | – |
| FY2017 | Dec 31, 2017 | -$10.06M | – |
| FY2016 | Dec 31, 2016 | -$103.57M | – |
| FY2015 | Dec 31, 2015 | -$124.34M | – |
| FY2014 | Dec 31, 2014 | -$57.27M | – |
| FY2013 | Dec 31, 2013 | -$46.92M | – |
| FY2012 | Dec 31, 2012 | -$47.93M | – |
| FY2011 | Dec 31, 2011 | -$20.77M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$25.31M | – |
| Q2 FY2026 | Jun 30, 2026 | $129.11M | – |
| Q1 FY2026 | Mar 31, 2026 | -$59.04M | -106.8% |
| Q4 FY2025 | Dec 31, 2025 | -$34.27M | – |
| Q3 FY2025 | Sep 30, 2025 | -$66.30M | – |
| Q2 FY2025 | Jun 30, 2025 | -$58.33M | – |
| Q1 FY2025 | Mar 31, 2025 | $870.10M | +1129.6% |
| Q4 FY2024 | Dec 31, 2024 | -$30.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$76.99M | – |
| Q2 FY2024 | Jun 30, 2024 | -$71.45M | – |
| Q1 FY2024 | Mar 31, 2024 | $70.76M | – |
| Q4 FY2023 | Dec 31, 2023 | -$100.29M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$29.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$165.96M | – |
| Q3 FY2022 | Sep 30, 2022 | -$38.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$55.24M | – |
| Q1 FY2022 | Mar 31, 2022 | -$97.40M | – |
| Q4 FY2021 | Dec 31, 2021 | -$68.84M | – |
| Q3 FY2021 | Sep 30, 2021 | -$51.19M | -292.0% |
| Q2 FY2021 | Jun 30, 2021 | -$31.15M | – |
| Q1 FY2021 | Mar 31, 2021 | -$100.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$64.37M | – |
| Q3 FY2020 | Sep 30, 2020 | $26.66M | – |
| Q2 FY2020 | Jun 30, 2020 | -$74.81M | – |
| Q1 FY2020 | Mar 31, 2020 | -$81.55M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.21M | – |
| Q3 FY2019 | Sep 30, 2019 | -$15.50M | -559.0% |
| Q2 FY2019 | Jun 30, 2019 | -$30.52M | -1017500.0% |
| Q1 FY2019 | Mar 31, 2019 | -$42.41M | – |
| Q4 FY2018 | Dec 31, 2018 | -$15.14M | -171.1% |
| Q3 FY2018 | Sep 30, 2018 | $3.38M | – |
| Q2 FY2018 | Jun 30, 2018 | $3.00K | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | -$15.88M | – |
| Q4 FY2017 | Dec 31, 2017 | $21.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$15.77M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.32M | – |
| Q1 FY2017 | Mar 31, 2017 | -$28.90M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.32M | – |
See a number that looks wrong?